© Synexa Life Sciences BV 2025
Blogs
- Resources
- Blogs
Latest Blogs
Validating Immunity: How ELISpot Data Shaped the AELIX-003 HIV Cure Trial
We are proud to share our laboratory’s role in a landmark clinical study published in Nature Communications, titled “Safety, immunogenicity and effect on viral rebound…
02 Jul, 2025 | Blogs
Video
From Pathways to Proof: Targeted Phosphoproteomics and PTM Analysis with LC-MS/MS
Quadrupole mass spectrometry (LC-MS/MS) has long established itself as the workhorse of bioanalysis for small molecules, valued for its high…
18 Jun, 2025 | Blogs
Video
Establishing Biosimilarity: Regulatory and Scientific Expectations
A biosimilar is defined as a biologic product, highly similar to a reference or originator, with no clinically meaningful differences…
05 Jun, 2025 | Blogs
Video
Why The Future Of Precision Medicine Will Be Defined By The Quality And Strategy Of Biomarker Signatures
We’re in the midst of a paradigm shift in biomarker science. No longer academic luxuries or exploratory afterthoughts, biomarker signatures…
15 May, 2025 | Blogs
Video
Radiopharmaceutical Drug Development: A Bioanalytical Lab Perspective
The radiopharmaceutical industry has traditionally experienced steady but modest growth, primarily driven by its established role in diagnostics and nuclear…
08 May, 2025 | Blogs
Video
Building a bioanalytical workflow for a vaccine study: The key assays and considerations
The COVID-19 pandemic put vaccines under the spotlight again, and from a scientific perspective at least, innovations have abounded.…
12 Mar, 2025 | Blogs
Video
Quantitative Analysis of Oligonucleotides: An out of the box LC-MS/MS approach
Oligonucleotide therapeutics have revolutionised the field of medicine over the last decade due to their potential for treating a broad…
05 Mar, 2025 | Blogs
